We are live on ! Find out more
GCM

Greywolf Capital Management Portfolio holdings

AUM $67.3M
1-Year Est. Return 100.05%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+100.05%
3 Year Est. Return
+174.41%
5 Year Est. Return
+148.91%
10 Year Est. Return
–
AUM
$662M
AUM Growth
+$290M
Cap. Flow
+$30M
Cap. Flow %
4.53%
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
5
Reduced
–
Closed
2
Avg Time Held Equity + Options
5.4 quarters
Top 10 Avg Time Held Equity + Options
5 quarters
Top 20 Avg Time Held Equity + Options
5.4 quarters
Avg Time Held Equity only
5.6 quarters
Top 10 Avg Time Held Equity only
5.5 quarters
Top 20 Avg Time Held Equity only
5.6 quarters

Top Buys

Rank Stock Value
1
MNKD icon
MannKind Corp
MNKD
+$18M
2
ZINC
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
+$14.3M
3
HMHC
Houghton Mifflin Harcourt Company
HMHC
+$10.9M
4
CSWC icon
Capital Southwest
CSWC
+$9.53M
5
RBY
RUBICON MENERALS CORP (F)
RBY
+$4.78M

Top Sells

Rank Stock Value
1
AMAG
AMAG Pharmaceuticals
AMAG
+$23.3M
2
CMBT
CMB.TECH NV
CMBT
+$4.22M

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.86%
2 Healthcare 15.57%
3 Industrials 15.04%
4 Communication Services 10.75%
5 Materials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$833B
$287M 43.39%
1,395,000
+300,000
+27% +$63.1M
2013 Q4
6 quarters
NPO icon
2
Enpro
NPO
$6.59B
$84.3M 12.74%
1,473,560
– –
2013 Q2
8 quarters
HMHC
3
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$71.2M 10.75%
2,824,000
+439,000
+18% +$10.9M
2015 Q1
1 quarter
MNKD icon
4
MannKind Corp
MNKD
$1.06B
$63.1M 9.53%
2,217,823
+705,423
+47% +$18M
2013 Q2
8 quarters
ZINC
5
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
$55.3M 8.36%
4,721,522
+1,096,222
+30% +$14.3M
2014 Q2
4 quarters
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$39.9M 6.03%
277,936
– –
2013 Q2
8 quarters
RBY
7
DELISTED
RUBICON MENERALS CORP (F)
RBY
$35.1M 5.31%
33,757,172
+4,440,630
+15% +$4.78M
2013 Q2
8 quarters
LXFR icon
8
Luxfer Holdings
LXFR
$465M
$15.3M 2.31%
1,173,815
– –
2013 Q2
8 quarters
CSWC icon
9
Capital Southwest
CSWC
$1.5B
$9.69M 1.46%
+528,734
New +$9.53M
2015 Q2
0 quarters
WLT
10
CALL
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$785K 0.12%
3,600,000
– –
2014 Q3
3 quarters
CMBT
11
CMB.TECH NV
CMBT
$5.98B
– –
-350,000
Closed -$4.22M –
AMAG
12
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-431,552
Closed -$23.3M –

Similar funds

MUS
Mitsubishi UFJ Securities Tokyo, Japan $69.4M AUM 17.25% 1-Year Est. Return
FVP
Firefly Value Partners Newtown, Pennsylvania $59.9M AUM 5.97% 1-Year Est. Return
FTIM
Flowering Tree Investment Management Singapore $57.2M AUM 50.6% 1-Year Est. Return
RMCP
Red Mountain Capital Partners Los Angeles, California $55.4M AUM 35.53% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
SCM
Stumpf Capital Management Scottsdale, Arizona $53.8M AUM 43.02% 1-Year Est. Return
OQC
Optimum Quantvest Corp Stamford, Connecticut $51.8M AUM 10.08% 1-Year Est. Return

Greywolf Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Greywolf Capital Management held 12 positions worth $662M, up 78% from $372M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Greywolf Capital Management deployed $30M of net new capital in Q2 2015, opening 1 new position and adding to 5 existing holdings. Its largest new stake was Capital Southwest: 528,734 shares worth $9.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the most notable exit was AMAG Pharmaceuticals, an estimated $23.3M sold.

  • Greywolf Capital Management's largest Q2 2015 buy was Capital Southwest: 528,734 shares worth $9.69M.
  • Greywolf Capital Management added most to MannKind Corp in Q2 2015, an estimated $18M increase.
  • Greywolf Capital Management fully exited AMAG Pharmaceuticals in Q2 2015, selling an estimated $23.3M.
  • Greywolf Capital Management's ten largest holdings make up 100% of its $662M portfolio in Q2 2015.
  • Greywolf Capital Management opened 1 new position and closed 2 in Q2 2015.
  • Greywolf Capital Management's portfolio value rose 78% quarter-over-quarter to $662M.

Based on Greywolf Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.